of consideration based on the Company’s consolidated financial statements as of 31 December 2019 audited by the certified auditor. There is no acquisition transaction to be incurred in the past 6

government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is

263.34 million. The Board of Directors authorized to The Executive Committee to have authority to consider the appropriateness and determine details essential and appropriate in this investment. This

, the debt financing is essential to support new project development and acquisitions. Thus, interest-bearing debts to equity from 0.85x to 1.48x as well as net interest-bearing debts to equity from 0.41x

Committee to have authority to consider the appropriateness and determine details essential and appropriate in this investment. This investment is not considered a transaction of a listed company under the

authority to consider the appropriateness and determine details essential and appropriate in this investment. This investment is not considered a transaction of a listed company under the Notification of the

addition, the economic impact of Covid-19 will be only fully visible in the Q2-Q4 period of the year. However, as our business is essential to many manufacturing processes, and as we are quite diversified

latest consolidated financial statements of the Company and its subsidiaries as of December 31, 2017 audited by the certified auditor, in which the size of transaction is below 15 percent and such

Maximize Solution Company Limited (“The Company”) would like to clarify the operating results for the second quarter ending 30 June 2017, which has been reviewed by the Certified Public Accountant. In the

Maximize Solution Company Limited (“The Company”) would like to report the operating results for the third quarter ending 30 September 2017, which has been reviewed by the Certified Public Accountant. In the